Literature DB >> 23160899

Interfering growth of malignant melanoma with Ang2-siRNA.

Biao Wang1, Zhaoliang Liu, Mingfeng Zhang, Xiuying San, Yanding Zhang, Weiqiang Zhang, Meishui Wang.   

Abstract

To investigate the intervention therapy effect on the growth of malignant melanoma, we have made an observation of expression levels of Ang2 in malignant melanoma cells, which was transduced by small interfering RNA (Ang2-siRNA) of Ang2 in vitro and in vivo. We successfully constructed Ang2-siRNA lent virus, and constructed nude mice model by transplanting malignant melanoma. Ang2-siRNA lent virus inhibited Ang2 mRNA of malignant melanoma in vitro and in vivo, and inhibited malignant melanoma tumor growth at the same time. Ang2-siRNA lent virus can interfere expression levels of Ang2 in malignant melanoma cells, inhibit tumor growth, and silent Ang2 gene expression, which may pave a new way for clinical gene therapy of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23160899      PMCID: PMC3538013          DOI: 10.1007/s11033-012-2189-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

1.  Genomic structures of the human angiopoietins show polymorphism in angiopoietin-2.

Authors:  E G Ward; K Grosios; A F Markham; P F Jones
Journal:  Cytogenet Cell Genet       Date:  2001

Review 2.  Unlocking the potential of the human genome with RNA interference.

Authors:  Gregory J Hannon; John J Rossi
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 3.  Illuminating the silence: understanding the structure and function of small RNAs.

Authors:  Tariq M Rana
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

4.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

Authors:  P C Maisonpierre; C Suri; P F Jones; S Bartunkova; S J Wiegand; C Radziejewski; D Compton; J McClain; T H Aldrich; N Papadopoulos; T J Daly; S Davis; T N Sato; G D Yancopoulos
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

5.  Angiogenesis and inflammation face off.

Authors:  Beat A Imhof; Michel Aurrand-Lions
Journal:  Nat Med       Date:  2006-02       Impact factor: 53.440

Review 6.  Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy.

Authors:  Guichun Huang; Longbang Chen
Journal:  Cancer Biother Radiopharm       Date:  2008-10       Impact factor: 3.099

7.  Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.

Authors:  Yi Tang; Marian T Nakada; Prabakaran Kesavan; Francis McCabe; Hillary Millar; Patricia Rafferty; Peter Bugelski; Li Yan
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

8.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 9.  Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.

Authors:  E J Battegay
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

10.  Induction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF.

Authors:  Momomi Saito; Maho Hamasaki; Masabumi Shibuya
Journal:  Cancer Sci       Date:  2003-09       Impact factor: 6.716

View more
  2 in total

1.  Construction of Ang2-siRNA chitosan magnetic nanoparticles and the effect on Ang2 gene expression in human malignant melanoma cells.

Authors:  Zhao-Liang Liu; Cai-Lian You; Biao Wang; Jian-Hong Lin; Xue-Feng Hu; Xiu-Ying Shan; Mei-Shui Wang; Hou-Bing Zheng; Yan-Ding Zhang
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

2.  Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids.

Authors:  Joana R Viola; Diana F Rafael; Ernst Wagner; Robert Besch; Manfred Ogris
Journal:  J Drug Deliv       Date:  2013-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.